Federated Hermes’s Pandion Therapeutics Inc. Common Stock PAND Stock Holding History

Federated Hermes’s Portfolio PAND Stock Details PAND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,049,240	Closed	-$63M	–	2418
2021 Q1	$63M	Buy	1,049,240 +249,240	+31%	+$9.02M	0.12%	218
2020 Q4	$11.9M	Buy	800,000 +200,000	+33%	+$2.78M	0.02%	598
2020 Q3	$6.88M	Buy	+600,000	New	+$10.3M	0.02%	658

Federated Hermes's PAND Position: Q2 2021 in Review

Federated Hermes sold out of Pandion Therapeutics Inc. Common Stock (PAND) in Q2 2021, closing a stake of 1,049,240 shares — an estimated $63M sold.

Federated Hermes first reported a position in PAND in Q3 2020 and held it in 3 quarters. The position peaked at $63M in Q1 2021. 0 funds tracked by Wall St. Rank hold PAND as of Q2 2021.

Federated Hermes reported no remaining Pandion Therapeutics Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Federated Hermes sold 1,049,240 Pandion Therapeutics Inc. Common Stock shares in Q2 2021, an estimated $63M.
Federated Hermes first reported a position in Pandion Therapeutics Inc. Common Stock in Q3 2020 and held it in 3 quarters.
Federated Hermes's Pandion Therapeutics Inc. Common Stock position peaked at $63M in Q1 2021.
0 funds tracked by Wall St. Rank held Pandion Therapeutics Inc. Common Stock as of Q2 2021.

Based on Federated Hermes's 13F filing for Q2 2021, filed 16 Aug 2021.